Background Patients with intracranial atherosclerotic stenosis (ICAS) are prone to stroke recurrence despite aggressive medical treatment. Further assessment of the anatomy and physiology of ICAS is ...

Background Transcranial Doppler (TCD) is a non-invasive, bedside tool that allows for real-time monitoring of the patient’s hemodynamic status following mechanical thrombectomy (MT). This systematic ...

Cerebral venous thrombosis (CVT) is a rare condition accounting for <1% of all strokes, with highly variable clinical presentations ranging from a headache to coma.1–4 Although MRI and MR venography ...

Background A study was undertaken to determine the typical length, diameter and taper of vessels in the anterior cerebral circulation. Methods The sample size was calculated at 100 patients based on ...

Background The role of catheter angiography in the diagnosis and management of traumatic cerebrovascular injury has evolved rapidly with advances in CT and MR angiography and continued development of ...

Background Several animal studies have demonstrated that mechanical thrombectomy (MT) for acute ischemic stroke (AIS) may cause vessel wall injury (VWI). However, the histological changes in human ...

Neurovascular catheter technology has rapidly evolved over the past decade. While performance characteristics are well known to the practitioner, the design features of these new-generation catheters ...

Purpose Lumbar spinal canal stenosis and lumbar spinal foraminal stenosis are common, degenerative pathologies which can result in neurogenic claudication and have a negative impact on function and ...

Objectives This is the first FDA approved IDE study for mechanical thrombectomy to treat distal occlusions. DISTALS is a randomized study planned to evaluate the safety and effectiveness of the ...

Background Interventional Management of Stroke III did not show that combining IV recombinant tissue plasminogen activator (rt-PA) with endovascular therapies (EVTs) is better than IV rt-PA alone.

Introduction The LVIS Blue is an FDA-approved stent with 28% metallic coverage that is indicated for use in conjunction with coil embolization for the treatment of intracranial aneurysms. Given a ...

Introduction. With the introduction of detachable coils by Guido Guglielmi in the early 1990s1 and the addition of adjunctive devices (intracranial stents, balloons, and pre-shaped and shapeable ...